VITALHUB CORP (VHI.CA) Stock Fundamental Analysis
TSX:VHI - Toronto Stock Exchange - CA92847V5018 - Common Stock - Currency: CAD
We assign a fundamental rating of 7 out of 10 to VHI. VHI was compared to 8 industry peers in the Health Care Technology industry. VHI gets an excellent profitability rating and is at the same time showing great financial health properties. VHI is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! With these ratings, VHI could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
In the past year VHI was profitable.
VHI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: VHI reported negative net income in multiple years.
Of the past 5 years VHI 4 years had a positive operating cash flow.
1.2 Ratios
The Return On Assets of VHI (1.16%) is better than 100.00% of its industry peers.
VHI has a Return On Equity of 1.58%. This is amongst the best in the industry. VHI outperforms 100.00% of its industry peers.
With an excellent Return On Invested Capital value of 3.04%, VHI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for VHI is in line with the industry average of 3.04%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.16% | ||
| ROE | 1.58% | ||
| ROIC | 3.04% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of VHI (3.79%) is better than 100.00% of its industry peers.
With an excellent Operating Margin value of 11.73%, VHI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
VHI's Operating Margin has improved in the last couple of years.
VHI has a better Gross Margin (80.86%) than 87.50% of its industry peers.
In the last couple of years the Gross Margin of VHI has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.73% | ||
| PM (TTM) | 3.79% | ||
| GM | 80.86% |
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VHI is destroying value.
Compared to 1 year ago, VHI has more shares outstanding
VHI has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, VHI has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 6.40 indicates that VHI is not in any danger for bankruptcy at the moment.
VHI has a better Altman-Z score (6.40) than 87.50% of its industry peers.
VHI has a debt to FCF ratio of 0.05. This is a very positive value and a sign of high solvency as it would only need 0.05 years to pay back of all of its debts.
The Debt to FCF ratio of VHI (0.05) is better than 87.50% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that VHI is not too dependend on debt financing.
The Debt to Equity ratio of VHI (0.00) is better than 87.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.05 | ||
| Altman-Z | 6.4 |
ROIC/WACC0.34
WACC9.04%
2.3 Liquidity
VHI has a Current Ratio of 2.35. This indicates that VHI is financially healthy and has no problem in meeting its short term obligations.
VHI's Current ratio of 2.35 is fine compared to the rest of the industry. VHI outperforms 75.00% of its industry peers.
VHI has a Quick Ratio of 2.34. This indicates that VHI is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.34, VHI is doing good in the industry, outperforming 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.35 | ||
| Quick Ratio | 2.34 |
3. Growth
3.1 Past
VHI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -53.85%.
Looking at the last year, VHI shows a very strong growth in Revenue. The Revenue has grown by 35.97%.
The Revenue has been growing by 46.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-53.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
Revenue 1Y (TTM)35.97%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%42.07%
3.2 Future
The Earnings Per Share is expected to grow by 82.32% on average over the next years. This is a very strong growth
VHI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.69% yearly.
EPS Next Y215.37%
EPS Next 2Y107.06%
EPS Next 3Y82.32%
EPS Next 5YN/A
Revenue Next Year30.64%
Revenue Next 2Y19.52%
Revenue Next 3Y26.69%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 181.50 indicates a quite expensive valuation of VHI.
100.00% of the companies in the same industry are more expensive than VHI, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.28, VHI is valued quite expensively.
The Price/Forward Earnings ratio is 36.29, which means the current valuation is very expensive for VHI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of VHI indicates a rather cheap valuation: VHI is cheaper than 100.00% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of VHI to the average of the S&P500 Index (21.76), we can say VHI is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 181.5 | ||
| Fwd PE | 36.29 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, VHI is valued cheaper than 87.50% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, VHI is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 40.94 | ||
| EV/EBITDA | 33.03 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of VHI may justify a higher PE ratio.
VHI's earnings are expected to grow with 82.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.84
PEG (5Y)N/A
EPS Next 2Y107.06%
EPS Next 3Y82.32%
5. Dividend
5.1 Amount
VHI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:VHI (7/2/2025, 7:00:00 PM)
10.89
-0.06 (-0.55%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners34.31%
Inst Owner ChangeN/A
Ins Owners12.77%
Ins Owner ChangeN/A
Market Cap607.44M
Analysts81.67
Price Target14.17 (30.12%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-44.15%
Min EPS beat(2)-54.3%
Max EPS beat(2)-33.99%
EPS beat(4)0
Avg EPS beat(4)-61.12%
Min EPS beat(4)-130.46%
Max EPS beat(4)-25.74%
EPS beat(8)1
Avg EPS beat(8)-29.63%
EPS beat(12)1
Avg EPS beat(12)-48.69%
EPS beat(16)2
Avg EPS beat(16)-88.33%
Revenue beat(2)2
Avg Revenue beat(2)2.65%
Min Revenue beat(2)0.61%
Max Revenue beat(2)4.69%
Revenue beat(4)3
Avg Revenue beat(4)2.04%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)4.69%
Revenue beat(8)6
Avg Revenue beat(8)2.98%
Revenue beat(12)9
Avg Revenue beat(12)2.56%
Revenue beat(16)11
Avg Revenue beat(16)2.78%
PT rev (1m)0.55%
PT rev (3m)2.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.35%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 181.5 | ||
| Fwd PE | 36.29 | ||
| P/S | 8.1 | ||
| P/FCF | 40.94 | ||
| P/OCF | 38.62 | ||
| P/B | 3.38 | ||
| P/tB | 12.03 | ||
| EV/EBITDA | 33.03 |
EPS(TTM)0.06
EY0.55%
EPS(NY)0.3
Fwd EY2.76%
FCF(TTM)0.27
FCFY2.44%
OCF(TTM)0.28
OCFY2.59%
SpS1.34
BVpS3.22
TBVpS0.91
PEG (NY)0.84
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.16% | ||
| ROE | 1.58% | ||
| ROCE | 4.46% | ||
| ROIC | 3.04% | ||
| ROICexc | 5.66% | ||
| ROICexgc | N/A | ||
| OM | 11.73% | ||
| PM (TTM) | 3.79% | ||
| GM | 80.86% | ||
| FCFM | 19.78% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
ROICexc(3y)5.88%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.82%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y132.1%
ROICexc growth 5YN/A
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
F-Score4
Asset Turnover0.31
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.05 | ||
| Debt/EBITDA | 0.02 | ||
| Cap/Depr | 13.02% | ||
| Cap/Sales | 1.19% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 100.49% | ||
| Profit Quality | 522.09% | ||
| Current Ratio | 2.35 | ||
| Quick Ratio | 2.34 | ||
| Altman-Z | 6.4 |
F-Score4
WACC9.04%
ROIC/WACC0.34
Cap/Depr(3y)9.42%
Cap/Depr(5y)8.61%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.89%
Profit Quality(3y)466.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
EPS Next Y215.37%
EPS Next 2Y107.06%
EPS Next 3Y82.32%
EPS Next 5YN/A
Revenue 1Y (TTM)35.97%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%42.07%
Revenue Next Year30.64%
Revenue Next 2Y19.52%
Revenue Next 3Y26.69%
Revenue Next 5YN/A
EBIT growth 1Y21.18%
EBIT growth 3Y217.15%
EBIT growth 5YN/A
EBIT Next Year62.54%
EBIT Next 3Y48.37%
EBIT Next 5YN/A
FCF growth 1Y308.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y293.07%
OCF growth 3YN/A
OCF growth 5YN/A